In contrast, mice treated with 1 × 106 or 5 × 106 iC9-CD19.ζ-MC-modified T cells showed early tumor control, which corresponded to acute weight loss in a CAR-T cell dose-dependent manner (Fig. 3a–c). Here, CD19 is linked to neoplasm.